Mesa Laboratories, Inc. (MLAB) P/E ratio
Mesa Laboratories, Inc. (MLAB) trades at 115.0× its earnings per share over the last twelve months. At the end of fiscal 2026 (March 31, 2026) its P/E ratio was 73.1×. Today's figure is 57.4% above the fiscal 2026 year-end. Figures as of 18 Nov 2026, 05:32 UTC, from the company's filings with the SEC and Yahoo Finance.
Key facts
- P/E ratio today
- 115.0×
- P/E ratio, fiscal 2026
- 73.1×
- Highest on record
- 380.5×fiscal 2021
- Lowest on record
- 15.5×fiscal 2011
- Fiscal years on record
- 102011–2026
Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.
Mesa Laboratories, Inc. P/E ratio, in more detail
Across the 10 fiscal year-ends on record (2011–2026), the highest was 380.5× in fiscal 2021 and the lowest 15.5× in fiscal 2011. Today's P/E ratio is higher than at 80% of the 10 fiscal year-ends on record; their median is 34.3×.
P/E ratio at each fiscal year-end
The last point is today's figure; the others are fiscal year-ends.
Mesa Laboratories, Inc. P/E ratio, year by year
| Fiscal year | P/E ratio | Change | Year ended | Share price at year-end | Diluted EPS |
|---|---|---|---|---|---|
| Today | 115.0× | — | $134.60 | — | |
| 2026 | 73.1× | — | $88.42 | $1.21 | |
| 2025 | — | — | $118.66 | -$0.36 | |
| 2024 | — | — | $109.73 | -$47.20 | |
| 2023 | — | — | $174.73 | $0.17 | |
| 2022 | — | — | $254.88 | $0.35 | |
| 2021 | 380.5× | — | $243.50 | $0.64 | |
| 2020 | — | — | $226.09 | $0.41 | |
| 2019 | 123.9× | — | $230.50 | $1.86 | |
| 2018 | — | — | $148.44 | -$0.79 | |
| 2017 | 42.2× | 30.0% up | $122.70 | $2.91 | |
| 2016 | 32.4× | 18.2% up | $96.35 | $2.97 | |
| 2015 | 27.5× | 24.3% down | $72.20 | $2.63 | |
| 2014 | 36.2× | 61.4% up | $90.25 | $2.49 | |
| 2013 | 22.5× | 4.3% up | $52.78 | $2.35 | |
| 2012 | 21.5× | 39.1% up | $49.32 | $2.29 | |
| 2011 | 15.5× | — | $28.80 | $1.86 |
Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.
How it is calculated
The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E.
How to read it
It is the number of years of current profit the price pays for — a high figure means investors expect growth, and it is best judged against the company's own history.
Mesa Laboratories, Inc., figure by figure
- Mesa Laboratories, Inc. market cap
- Mesa Laboratories, Inc. revenue
- Mesa Laboratories, Inc. earnings
- Mesa Laboratories, Inc. earnings per share (EPS)
- Mesa Laboratories, Inc. P/S ratio
- Mesa Laboratories, Inc. P/B ratio
- Mesa Laboratories, Inc. free cash flow
- Mesa Laboratories, Inc. operating margin
- Mesa Laboratories, Inc. dividend
- Mesa Laboratories, Inc. shares outstanding
- Mesa Laboratories, Inc. total debt
- Mesa Laboratories, Inc. cash on hand
- Mesa Laboratories, Inc. total assets
- Mesa Laboratories, Inc. return on equity (ROE)
- Mesa Laboratories, Inc. return on invested capital (ROIC)
Mesa Laboratories, Inc. (MLAB) overview: price, valuation and scorecard
Mesa Laboratories, Inc. P/E ratio: questions and answers
What is Mesa Laboratories, Inc.'s P/E ratio?
Mesa Laboratories, Inc. (MLAB) trades at 115.0× its earnings per share over the last twelve months. At the end of fiscal 2026 (March 31, 2026) its P/E ratio was 73.1×.
Is Mesa Laboratories, Inc.'s P/E ratio high or low compared with its own history?
Today's P/E ratio is higher than at 80% of the 10 fiscal year-ends on record; their median is 34.3×.
What are the highest and lowest P/E ratio figures on record for Mesa Laboratories, Inc.?
Across the 10 fiscal year-ends on record (2011–2026), the highest was 380.5× in fiscal 2021 and the lowest 15.5× in fiscal 2011.
How is Mesa Laboratories, Inc.'s P/E ratio calculated?
The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E.
Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.
Learn: P/E ratio
All stocks guides →- P/E ratio explained: what a high or low figure means
The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- PEG ratio: P/E adjusted for growth, and its limits
The PEG ratio is a stock's P/E divided by its expected yearly earnings growth in percent. A P/E of 20 with 10% expected growth gives a PEG of 2; with 20% growth, a PEG of 1. A PEG near 1 is the traditional rough mark of a fair price, but the growth figure is a forecast and often wrong.
- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
Cite this page
Funkfolio, “Mesa Laboratories, Inc. (MLAB) P/E ratio”, data as of 18 November 2026. https://funkfolio.com/stock/MLAB/pe-ratio
Underlying data: the company's filings with the SEC and Yahoo Finance.